Will CVs become evergreen capital’s next battleground?

While some investors recognise the benefits of evergreen funds participating in GP-led deals, others view the space as a ‘wild west’ that requires greater discipline.

SECONDARIES INVESTOR

Register to unlock this content

• Daily global secondaries market news and intelligence
• Curated insights to keep you ahead of GP-led and LP-led secondaries
• Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
• Access to proprietary research and reports
• Selected fund performance and investor activity data

Register nowFind out more

CommentaryEditor's ViewGP-Leds